The role of CD117 expression has been investigated in human medicine across various tumors (15–21), and its dysregulation has been shown to have implications in the development of gastrointestinal stromal tumors (GISTs), melanomas, acute myeloid leukemias (AMLs), and seminomas (16, 22). The gene discussed is KIT; the disease is melanoma.